Who owns Newamsterdam Pharma Company (NAMS)? Superinvestor holders

5 superinvestors of the 157 tracked here hold Newamsterdam Pharma Company (NAMS) in their latest 13F filing, with $688.7M between them. Peter Kolchinsky gives it the most weight: 2.81% of the reported portfolio. In their latest reported quarter, Lee Ainslie added.

Ron Baron sold out of it in their latest quarter.

Hold it now
5
of 157 tracked
Combined value
$688.7M
Bought / sold
1 / 1
last quarter

Key facts

Superinvestors holding it
5 of 157
Biggest holder
Peter Kolchinsky, $323.7M
Largest weight
Peter Kolchinsky, 2.81%of their portfolio
Combined value
$688.7M
Bought last quarter
1
Sold last quarter
1

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding NAMS, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Peter KolchinskyRA Capital Management2.81%$323.7M9.55MNo change0Q2 2026
2Stanley DruckenmillerDuquesne Family Office2.39%$104M3.07MNo change0Q2 2026
3Lee AinslieMaverick Capital1.00%$110.7M3.27M▲ Added 49%+1.08MQ2 2026
4Andreas HalvorsenViking Global Investors0.41%$142.5M4.2MNo change0Q2 2026
5David GreenspanSlate Path Capital0.12%$7.8M319KNo change0Q3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of NAMS by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 2026921319K$7.8M01
Q2 2026157520.41M$691.7M10
Q1 2026157519.33M$618.7M11
Q4 2025157519.04M$667.8M22
Q3 2025157520.36M$579.1M12
Q2 2025157519.8M$358.6M20
Q1 2025156518.79M$384.6M30
Q4 2024156516.78M$431.2M32

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of NAMS held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
David Greenspan319K319K319K319K319K319K319K319K
Peter Kolchinsky·9.55M9.55M9.55M10.14M10.14M10.14M8.85M
Andreas Halvorsen·4.2M4.2M4.2M6.48M6.98M6.98M6.98M
Lee Ainslie·3.27M2.19M1.89M1.5M1.53M549.47K350.01K
Stanley Druckenmiller·3.07M3.07M3.07M1.92M832.18K800.36K287.54K

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own NAMS?

In their latest 13F filings: Peter Kolchinsky (2.81% of the portfolio, $323.7M), Stanley Druckenmiller (2.39% of the portfolio, $104M), Lee Ainslie (1.00% of the portfolio, $110.7M), Andreas Halvorsen (0.41% of the portfolio, $142.5M), David Greenspan (0.12% of the portfolio, $7.8M).

Who bought NAMS last quarter?

Lee Ainslie (added 49%). “Last quarter” is each investor's latest reported quarter.

Who sold NAMS last quarter?

Sold out entirely: Ron Baron (was $305K).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Newamsterdam Pharma Company (NAMS)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/NAMS/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to NAMS by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.